Methotrexate kinetics in myeloid bone marrow cells and peripheral neutrophils
✍ Scribed by Henrik Schrøder
- Publisher
- Springer
- Year
- 1987
- Tongue
- English
- Weight
- 505 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0344-5704
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Methotrexate (MTX) was administered by continual intravenous infusion for 24 hours in doses ranging from 200-800 mg/m2 to 16 patients who had metastatic cancers and normal bone marrows and 11 patients with acute leukemia. Citrovorum factor (CF) was administered every 6 hours for 12-15 doses beginnin
## Abstract The case of a 73‐year‐old man with B‐cell prolymphocytic leukemia (PLL) and rapid clinical demise is reported. Flow cytometric immunophenotyping results of specimens obtained from the patient demonstrated a monoclonal CD5 positive B‐cell population with myeloid‐associated marker express